These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 36596363)

  • 1. A Primer on the History of Intralesional Verapamil Injection for Peyronie's Disease.
    Levine LA
    Urology; 2023 Mar; 173():5-7. PubMed ID: 36596363
    [No Abstract]   [Full Text] [Related]  

  • 2. Intralesional injection of the calcium channel blocker Verapamil in Peyronie's disease: A critical review.
    Asali M; Asali M
    Arch Ital Urol Androl; 2020 Oct; 92(3):. PubMed ID: 33016057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A snapshot of intralesional verapamil injection in the treatment of Peyronie's disease today.
    Sadagopan A
    Andrologia; 2019 Nov; 51(10):e13388. PubMed ID: 31475740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Review of Peyronie's disease].
    Stein A; Dekel Y
    Harefuah; 2012 Nov; 151(11):638-40, 653. PubMed ID: 23367736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intralesional verapamil prevents the progression of Peyronie's disease.
    Bennett NE; Guhring P; Mulhall JP
    Urology; 2007 Jun; 69(6):1181-4. PubMed ID: 17572211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of intralesional injection of hyaluronic acid compared with verapamil in Peyronie's disease: preliminary results from a prospective, double-blinded, randomized study.
    Favilla V; Russo GI; Zucchi A; Siracusa G; Privitera S; Cimino S; Madonia M; Cai T; Cavallini G; Liguori G; D'Achille G; Silvani M; Franco G; Verze P; Palmieri A; Torrisi B; Mirone V; Morgia G
    Andrology; 2017 Jul; 5(4):771-775. PubMed ID: 28718527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is intralesional verapamil effective therapy for Peyronie's disease?
    Levine LA; Costabile RA
    J Urol; 2012 Sep; 188(3):704-6. PubMed ID: 22818342
    [No Abstract]   [Full Text] [Related]  

  • 8. Intralesional verapamil for the treatment of Peyronie's disease: a review.
    Levine LA; Estrada CR
    Int J Impot Res; 2002 Oct; 14(5):324-8. PubMed ID: 12454681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intralesional verapamil injection for the treatment of Peyronie's disease.
    Levine LA; Merrick PF; Lee RC
    J Urol; 1994 Jun; 151(6):1522-4. PubMed ID: 8189561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of intralesional verapamil to dissolve Peyronie's disease plaque: a long-term single-blind study.
    Rehman J; Benet A; Melman A
    Urology; 1998 Apr; 51(4):620-6. PubMed ID: 9586617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative Effectiveness of Intralesional Therapy for Peyronie's Disease in Controlled Clinical Studies: A Systematic Review and Network Meta-Analysis.
    Russo GI; Cacciamani G; Cocci A; Kessler TM; Morgia G; Serefoglu EC; Albersen M; Verze P;
    J Sex Med; 2019 Feb; 16(2):289-299. PubMed ID: 30692028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of intralesional verapamil for treatment of Peyronie's disease: a randomized single-blind, placebo-controlled study.
    Shirazi M; Haghpanah AR; Badiee M; Afrasiabi MA; Haghpanah S
    Int Urol Nephrol; 2009; 41(3):467-71. PubMed ID: 19199072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective, randomized, single - blind study comparing intraplaque injection of thiocolchicine and verapamil in Peyronie's Disease: a pilot study.
    Toscano L; Rezende MV; Mello LF; Paulillo D; Glina S
    Int Braz J Urol; 2016; 42(5):1005-1009. PubMed ID: 24893912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of intralesional injection of verapamil in treatment of Peyronie's disease.
    Heidari M; Nejadi JR; Ghate A; Delfan B; Iran-Pour E
    J Pak Med Assoc; 2010 Apr; 60(4):291-3. PubMed ID: 20419973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intralesional Injection Therapy and Atypical Peyronie's Disease: A Systematic Review.
    Choi EJ; Xu P; El-Khatib FM; Yafi FA
    Sex Med Rev; 2021 Jul; 9(3):434-444. PubMed ID: 32660728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intralesional injection therapy for Peyronie's disease.
    Hellstrom WJ; Cockerham YR
    J Sex Med; 2009 Jul; 6(7):1811-4. PubMed ID: 19575773
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical effects of verapamil in the treatment of Peyronie's disease].
    Arena F; Peracchia G; Di Stefano C; Passari A; Larosa M; Cortellini P
    Acta Biomed Ateneo Parmense; 1995; 66(6):269-72. PubMed ID: 8928594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological therapy in patients diagnosed with Peyronie's disease.
    Halal AA; Geavlete P; Ceban E
    J Med Life; 2012 Jun; 5(2):192-5. PubMed ID: 22802890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological Management of Peyronie's Disease.
    Trost LW; Gur S; Hellstrom WJ
    Drugs; 2007; 67(4):527-45. PubMed ID: 17352513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of Peyronie's disease with intralesional verapamil injection.
    Levine LA
    J Urol; 1997 Oct; 158(4):1395-9. PubMed ID: 9302129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.